Provider location, no. (%) |
|
|
|
0.98 |
Emergency room |
127 (43.3) |
97 (43.3) |
30 (43.5) |
|
Primary care |
166 (56.7) |
127 (56.7) |
39 (56.5) |
|
Antibiotic prescribed, no. (%) |
|
|
|
0.89 |
Cephalexin |
87 (29.7) |
68 (30.4) |
19 (27.5) |
|
Clindamycin |
45 (15.4) |
35 (15.6) |
10 (14.5) |
|
TMP-SMX |
96 (32.8) |
71 (31.7) |
25 (36.2) |
|
TMP plus cephalexin |
8 (2.7) |
7 (3.1) |
1 (1.4) |
|
Other |
57 (19.4) |
43 (19.2) |
14 (20.3) |
|
Duration of treatment (days), mean ± SD |
9.0 ± 1.92 |
8.94 ± 2.01 |
9.14 ± 1.59 |
0.43 |
Anatomic area, no. (%) |
|
|
|
0.66 |
Buttocks/groin |
20 (6.8) |
14 (6.2) |
6 (8.7) |
|
Head/neck |
50 (17.1) |
38 (17) |
12 (17.4) |
|
Lower extremity |
172 (58.7) |
129 (57.6) |
43 (62.3) |
|
Trunk/abdomen |
13 (4.4) |
11 (4.9) |
2 (2.9) |
|
Upper extremity |
38 (13) |
32 (14.3) |
6 (8.7) |
|
Incision and drainage, no. (%) |
51 (17.4) |
38 (20) |
13 (18.8) |
0.72 |
Type of infection, no. (%) |
|
|
|
0.77 |
Abscess |
67 (22.9) |
49 (21.9) |
18 (26.1) |
|
Cellulitis |
182 (62.1) |
141 (62.9) |
41 (59.4) |
|
Mixed |
44 (15) |
34 (15.2) |
10 (14.5) |
|
Culture result (n = 45), no. (%) |
|
|
|
0.012 |
Gram negative |
1 (2.2) |
1 (3.2) |
0 |
|
MRSA |
14 (31.1) |
5 (16.1) |
9 (64.3) |
|
S. aureus
|
16 (35.6) |
12 (38.7) |
4 (28.6) |
|
Skin flora |
11 (24.4) |
11 (35.5) |
0 |
|
No growth |
3 (6.7) |
2 (6.4) |
1 (7.1) |
|
Hospitalization within 30 days, no. (%) |
15 (5.1) |
1 (0.5) |
14 (20.3) |
<0.0001 |